Xiaoping Cen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoping Cen has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Yixue Li
Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China
3 shared publications Dragomirka Jovic
BGI Research
2 shared publicationsFred Dubee
BGI Research
2 shared publicationsHuanming Yang
College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China (X.C., H.Y.); HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China (X.C., H.Y., W.D.); BGI, Shenzhen 518083, China (H.Y.); James D. Watson Institute of Genome Sciences, Hangzhou 310029, China (H.Y.).
2 shared publicationsWei Dong
HIM‐BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS)
2 shared publicationsYahan Tong
Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
2 shared publications
Latest Publications
- Open Access
Single‐Cell and Spatial Omics: Methods and Applications
Single‐cell and spatial omics have revolutionized biomedical research by enabling high‐resolution molecular profiling across cells and tissues, thereby overcoming key limitations of bulk sequencing and revealing unprecedented cellular heterogeneity and spatial organization central to development, homeostasis, and disease. Specifically, advances in high‐throughput, subcellular, and multiomics profiling are promoting the field toward deeper insights. In parallel, computational progress, including generative artificial intelligence (AI) and foundation models, is developing rapidly for manipulating multimodal multiomics data. These advancements have been applied to diverse diseases and biological systems, facilitating innovative biomedical findings. However, a significant gap persists between rapid methodological advances and their systematic application for deciphering human biology and pathology. This review synthesizes recent breakthroughs in single‐cell and spatial technologies and surveys computational methods, including AI‐driven approaches, foundation models, and multi‐omics integration algorithms for both single‐cell and spatial analyses. We then summarize representative applications across major human organ systems in health and disease, highlighting opportunities for biomarker discovery, therapeutic target identification, and precision medicine. Finally, we discuss current challenges and future directions for bridging technological innovation with robust biomedical discovery and translational impact. This review provides a vital guide for researchers in the field, offering critical insights for accelerating the translation of single‐cell and spatial omics.
Open AccessSingle‐Cell and Spatial Omics: Methods and Applications
Single‐cell and spatial omics have revolutionized biomedical research by enabling high‐resolution molecular profiling across cells and tissues, thereby overcoming key limitations of bulk sequencing and revealing unprecedented cellular heterogeneity and spatial organization central to development, homeostasis, and disease. Specifically, advances in high‐throughput, subcellular, and multiomics profiling are promoting the field toward deeper insights. In parallel, computational progress, including generative artificial intelligence (AI) and foundation models, is developing rapidly for manipulating multimodal multiomics data. These advancements have been applied to diverse diseases and biological systems, facilitating innovative biomedical findings. However, a significant gap persists between rapid methodological advances and their systematic application for deciphering human biology and pathology. This review synthesizes recent breakthroughs in single‐cell and spatial technologies and surveys computational methods, including AI‐driven approaches, foundation models, and multi‐omics integration algorithms for both single‐cell and spatial analyses. We then summarize representative applications across major human organ systems in health and disease, highlighting opportunities for biomarker discovery, therapeutic target identification, and precision medicine. Finally, we discuss current challenges and future directions for bridging technological innovation with robust biomedical discovery and translational impact. This review provides a vital guide for researchers in the field, offering critical insights for accelerating the translation of single‐cell and spatial omics.
- Open Access
- 22 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 45 (7) , 728-746
Pan‐cancer analysis shapes the understanding of cancer biology and medicine
Advances in multi‐omics datasets and analytical methods have revolutionized cancer research, offering a comprehensive, pan‐cancer perspective. Pan‐cancer studies identify shared mechanisms and unique traits across different cancer types, which are reshaping diagnostic and treatment strategies. However, continued innovation is required to refine these approaches and deepen our understanding of cancer biology and medicine. This review summarized key findings from pan‐cancer research and explored their potential to drive future advancements in oncology.
- 22 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 45 (7) , 728-746
Open AccessPan‐cancer analysis shapes the understanding of cancer biology and medicine
Advances in multi‐omics datasets and analytical methods have revolutionized cancer research, offering a comprehensive, pan‐cancer perspective. Pan‐cancer studies identify shared mechanisms and unique traits across different cancer types, which are reshaping diagnostic and treatment strategies. However, continued innovation is required to refine these approaches and deepen our understanding of cancer biology and medicine. This review summarized key findings from pan‐cancer research and explored their potential to drive future advancements in oncology.
- Top Cited PapersOpen Access
- 27 February 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (1)
Challenges in AI-driven Biomedical Multimodal Data Fusion and Analysis
The rapid development of biological and medical examination methods has vastly expanded personal biomedical information, including molecular, cellular, image, and electronic health record datasets. Integrating this wealth of information enables precise disease diagnosis, biomarker identification, and treatment design in clinical settings. Artificial intelligence (AI) techniques, particularly deep learning models, have been extensively employed in biomedical applications, demonstrating increased precision, efficiency, and generalization. The success of the large language and vision models further significantly extends their biomedical applications. However, challenges remain in learning these multimodal biomedical datasets, such as data privacy, fusion, and model interpretation. In this review, we provide a comprehensive overview of various biomedical data modalities, multimodal representation learning methods, and the applications of AI in biomedical data integrative analysis. Additionally, we discuss the challenges in applying these deep learning methods and how to better integrate them into biomedical scenarios. We then propose future directions for adapting deep learning methods with model pretraining and knowledge integration to advance biomedical research and benefit their clinical applications.
- 27 February 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (1)
Top Cited PapersOpen AccessChallenges in AI-driven Biomedical Multimodal Data Fusion and Analysis
The rapid development of biological and medical examination methods has vastly expanded personal biomedical information, including molecular, cellular, image, and electronic health record datasets. Integrating this wealth of information enables precise disease diagnosis, biomarker identification, and treatment design in clinical settings. Artificial intelligence (AI) techniques, particularly deep learning models, have been extensively employed in biomedical applications, demonstrating increased precision, efficiency, and generalization. The success of the large language and vision models further significantly extends their biomedical applications. However, challenges remain in learning these multimodal biomedical datasets, such as data privacy, fusion, and model interpretation. In this review, we provide a comprehensive overview of various biomedical data modalities, multimodal representation learning methods, and the applications of AI in biomedical data integrative analysis. Additionally, we discuss the challenges in applying these deep learning methods and how to better integrate them into biomedical scenarios. We then propose future directions for adapting deep learning methods with model pretraining and knowledge integration to advance biomedical research and benefit their clinical applications.
- 3 February 2025
- Published by Elsevier in Academic Radiology
- Vol. 32 (3) , 1771-1772
A Deep Radiomics Model for Lymph Node Metastasis Prediction of Early-Stage Gastric Cancer Based on CT Images
- 3 February 2025
- Published by Elsevier in Academic Radiology
- Vol. 32 (3) , 1771-1772
A Deep Radiomics Model for Lymph Node Metastasis Prediction of Early-Stage Gastric Cancer Based on CT Images
- 18 September 2023
- Published by Elsevier in Information Fusion
- Vol. 102
Towards interpretable imaging genomics analysis: Methodological developments and applications
- 18 September 2023
- Published by Elsevier in Information Fusion
- Vol. 102
Towards interpretable imaging genomics analysis: Methodological developments and applications